世界の重水素置換治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Deuterium-substituteddrugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1810
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、重水素置換治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治験薬、市販薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・重水素置換治療薬の市場動向
・企業の競争状況、市場シェア
・重水素置換治療薬の種類別市場規模（治験薬、市販薬）
・重水素置換治療薬の用途別市場規模（病院、クリニック、その他）
・重水素置換治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・重水素置換治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・重水素置換治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・重水素置換治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・重水素置換治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Teva、Bristol-Myers Squibb、Retrotope、Alkeus、Avanir、Concert、Processa、Vertex、Jazz Pharmaceuticals、Zelgen、Hinova Pharmaceuticals Inc.）
・結論

Deuterium is the replacement of hydrogen atoms with deuterium atoms in one or more of the c-h bonds in a compound molecule.

Market Analysis and Insights: Global Deuterium-substituteddrugs Market
The global Deuterium-substituteddrugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Deuterium-substituteddrugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Deuterium-substituteddrugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Deuterium-substituteddrugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Deuterium-substituteddrugs market.

Global Deuterium-substituteddrugs Scope and Market Size
Deuterium-substituteddrugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deuterium-substituteddrugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs in Clinical Trials
Marketed Drug

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Bristol-Myers Squibb
Retrotope
Alkeus
Avanir
Concert
Processa
Vertex
Jazz Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deuterium-substituteddrugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs in Clinical Trials
1.2.3 Marketed Drug
1.3 Market by Application
1.3.1 Global Deuterium-substituteddrugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Deuterium-substituteddrugs Market Perspective (2016-2027)
2.2 Deuterium-substituteddrugs Growth Trends by Regions
2.2.1 Deuterium-substituteddrugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Deuterium-substituteddrugs Historic Market Share by Regions (2016-2021)
2.2.3 Deuterium-substituteddrugs Forecasted Market Size by Regions (2022-2027)
2.3 Deuterium-substituteddrugs Industry Dynamic
2.3.1 Deuterium-substituteddrugs Market Trends
2.3.2 Deuterium-substituteddrugs Market Drivers
2.3.3 Deuterium-substituteddrugs Market Challenges
2.3.4 Deuterium-substituteddrugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Deuterium-substituteddrugs Players by Revenue
3.1.1 Global Top Deuterium-substituteddrugs Players by Revenue (2016-2021)
3.1.2 Global Deuterium-substituteddrugs Revenue Market Share by Players (2016-2021)
3.2 Global Deuterium-substituteddrugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Deuterium-substituteddrugs Revenue
3.4 Global Deuterium-substituteddrugs Market Concentration Ratio
3.4.1 Global Deuterium-substituteddrugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deuterium-substituteddrugs Revenue in 2020
3.5 Deuterium-substituteddrugs Key Players Head office and Area Served
3.6 Key Players Deuterium-substituteddrugs Product Solution and Service
3.7 Date of Enter into Deuterium-substituteddrugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Deuterium-substituteddrugs Breakdown Data by Type
4.1 Global Deuterium-substituteddrugs Historic Market Size by Type (2016-2021)
4.2 Global Deuterium-substituteddrugs Forecasted Market Size by Type (2022-2027)

5 Deuterium-substituteddrugs Breakdown Data by Application
5.1 Global Deuterium-substituteddrugs Historic Market Size by Application (2016-2021)
5.2 Global Deuterium-substituteddrugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Deuterium-substituteddrugs Market Size (2016-2027)
6.2 North America Deuterium-substituteddrugs Market Size by Type
6.2.1 North America Deuterium-substituteddrugs Market Size by Type (2016-2021)
6.2.2 North America Deuterium-substituteddrugs Market Size by Type (2022-2027)
6.2.3 North America Deuterium-substituteddrugs Market Size by Type (2016-2027)
6.3 North America Deuterium-substituteddrugs Market Size by Application
6.3.1 North America Deuterium-substituteddrugs Market Size by Application (2016-2021)
6.3.2 North America Deuterium-substituteddrugs Market Size by Application (2022-2027)
6.3.3 North America Deuterium-substituteddrugs Market Size by Application (2016-2027)
6.4 North America Deuterium-substituteddrugs Market Size by Country
6.4.1 North America Deuterium-substituteddrugs Market Size by Country (2016-2021)
6.4.2 North America Deuterium-substituteddrugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Deuterium-substituteddrugs Market Size (2016-2027)
7.2 Europe Deuterium-substituteddrugs Market Size by Type
7.2.1 Europe Deuterium-substituteddrugs Market Size by Type (2016-2021)
7.2.2 Europe Deuterium-substituteddrugs Market Size by Type (2022-2027)
7.2.3 Europe Deuterium-substituteddrugs Market Size by Type (2016-2027)
7.3 Europe Deuterium-substituteddrugs Market Size by Application
7.3.1 Europe Deuterium-substituteddrugs Market Size by Application (2016-2021)
7.3.2 Europe Deuterium-substituteddrugs Market Size by Application (2022-2027)
7.3.3 Europe Deuterium-substituteddrugs Market Size by Application (2016-2027)
7.4 Europe Deuterium-substituteddrugs Market Size by Country
7.4.1 Europe Deuterium-substituteddrugs Market Size by Country (2016-2021)
7.4.2 Europe Deuterium-substituteddrugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Deuterium-substituteddrugs Market Size (2016-2027)
8.2 Asia-Pacific Deuterium-substituteddrugs Market Size by Type
8.2.1 Asia-Pacific Deuterium-substituteddrugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Deuterium-substituteddrugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Deuterium-substituteddrugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Deuterium-substituteddrugs Market Size by Application
8.3.1 Asia-Pacific Deuterium-substituteddrugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Deuterium-substituteddrugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Deuterium-substituteddrugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Deuterium-substituteddrugs Market Size by Region
8.4.1 Asia-Pacific Deuterium-substituteddrugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Deuterium-substituteddrugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Deuterium-substituteddrugs Market Size (2016-2027)
9.2 Latin America Deuterium-substituteddrugs Market Size by Type
9.2.1 Latin America Deuterium-substituteddrugs Market Size by Type (2016-2021)
9.2.2 Latin America Deuterium-substituteddrugs Market Size by Type (2022-2027)
9.2.3 Latin America Deuterium-substituteddrugs Market Size by Type (2016-2027)
9.3 Latin America Deuterium-substituteddrugs Market Size by Application
9.3.1 Latin America Deuterium-substituteddrugs Market Size by Application (2016-2021)
9.3.2 Latin America Deuterium-substituteddrugs Market Size by Application (2022-2027)
9.3.3 Latin America Deuterium-substituteddrugs Market Size by Application (2016-2027)
9.4 Latin America Deuterium-substituteddrugs Market Size by Country
9.4.1 Latin America Deuterium-substituteddrugs Market Size by Country (2016-2021)
9.4.2 Latin America Deuterium-substituteddrugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Deuterium-substituteddrugs Market Size (2016-2027)
10.2 Middle East & Africa Deuterium-substituteddrugs Market Size by Type
10.2.1 Middle East & Africa Deuterium-substituteddrugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Deuterium-substituteddrugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Deuterium-substituteddrugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Deuterium-substituteddrugs Market Size by Application
10.3.1 Middle East & Africa Deuterium-substituteddrugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Deuterium-substituteddrugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Deuterium-substituteddrugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Deuterium-substituteddrugs Market Size by Country
10.4.1 Middle East & Africa Deuterium-substituteddrugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Deuterium-substituteddrugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Deuterium-substituteddrugs Introduction
11.1.4 Teva Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Deuterium-substituteddrugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Retrotope
11.3.1 Retrotope Company Details
11.3.2 Retrotope Business Overview
11.3.3 Retrotope Deuterium-substituteddrugs Introduction
11.3.4 Retrotope Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.3.5 Retrotope Recent Development
11.4 Alkeus
11.4.1 Alkeus Company Details
11.4.2 Alkeus Business Overview
11.4.3 Alkeus Deuterium-substituteddrugs Introduction
11.4.4 Alkeus Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.4.5 Alkeus Recent Development
11.5 Avanir
11.5.1 Avanir Company Details
11.5.2 Avanir Business Overview
11.5.3 Avanir Deuterium-substituteddrugs Introduction
11.5.4 Avanir Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.5.5 Avanir Recent Development
11.6 Concert
11.6.1 Concert Company Details
11.6.2 Concert Business Overview
11.6.3 Concert Deuterium-substituteddrugs Introduction
11.6.4 Concert Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.6.5 Concert Recent Development
11.7 Processa
11.7.1 Processa Company Details
11.7.2 Processa Business Overview
11.7.3 Processa Deuterium-substituteddrugs Introduction
11.7.4 Processa Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.7.5 Processa Recent Development
11.8 Vertex
11.8.1 Vertex Company Details
11.8.2 Vertex Business Overview
11.8.3 Vertex Deuterium-substituteddrugs Introduction
11.8.4 Vertex Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.8.5 Vertex Recent Development
11.9 Jazz Pharmaceuticals
11.9.1 Jazz Pharmaceuticals Company Details
11.9.2 Jazz Pharmaceuticals Business Overview
11.9.3 Jazz Pharmaceuticals Deuterium-substituteddrugs Introduction
11.9.4 Jazz Pharmaceuticals Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.9.5 Jazz Pharmaceuticals Recent Development
11.10 Zelgen
11.10.1 Zelgen Company Details
11.10.2 Zelgen Business Overview
11.10.3 Zelgen Deuterium-substituteddrugs Introduction
11.10.4 Zelgen Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.10.5 Zelgen Recent Development
11.11 Hinova Pharmaceuticals Inc.
11.11.1 Hinova Pharmaceuticals Inc. Company Details
11.11.2 Hinova Pharmaceuticals Inc. Business Overview
11.11.3 Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Introduction
11.11.4 Hinova Pharmaceuticals Inc. Revenue in Deuterium-substituteddrugs Business (2016-2021)
11.11.5 Hinova Pharmaceuticals Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Deuterium-substituteddrugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs in Clinical Trials
Table 3. Key Players of Marketed Drug
Table 4. Global Deuterium-substituteddrugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Deuterium-substituteddrugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Deuterium-substituteddrugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Deuterium-substituteddrugs Market Share by Regions (2016-2021)
Table 8. Global Deuterium-substituteddrugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Deuterium-substituteddrugs Market Share by Regions (2022-2027)
Table 10. Deuterium-substituteddrugs Market Trends
Table 11. Deuterium-substituteddrugs Market Drivers
Table 12. Deuterium-substituteddrugs Market Challenges
Table 13. Deuterium-substituteddrugs Market Restraints
Table 14. Global Deuterium-substituteddrugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Deuterium-substituteddrugs Market Share by Players (2016-2021)
Table 16. Global Top Deuterium-substituteddrugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deuterium-substituteddrugs as of 2020)
Table 17. Ranking of Global Top Deuterium-substituteddrugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Deuterium-substituteddrugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Deuterium-substituteddrugs Product Solution and Service
Table 21. Date of Enter into Deuterium-substituteddrugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Deuterium-substituteddrugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Deuterium-substituteddrugs Revenue Market Share by Type (2016-2021)
Table 25. Global Deuterium-substituteddrugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Deuterium-substituteddrugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Deuterium-substituteddrugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Deuterium-substituteddrugs Revenue Market Share by Application (2016-2021)
Table 29. Global Deuterium-substituteddrugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Deuterium-substituteddrugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Deuterium-substituteddrugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Deuterium-substituteddrugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Deuterium-substituteddrugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Deuterium-substituteddrugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Deuterium-substituteddrugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Deuterium-substituteddrugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Deuterium-substituteddrugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Deuterium-substituteddrugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Deuterium-substituteddrugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Deuterium-substituteddrugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Deuterium-substituteddrugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Deuterium-substituteddrugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Deuterium-substituteddrugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Deuterium-substituteddrugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Deuterium-substituteddrugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Deuterium-substituteddrugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Deuterium-substituteddrugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Deuterium-substituteddrugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Deuterium-substituteddrugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Deuterium-substituteddrugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Deuterium-substituteddrugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Deuterium-substituteddrugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Deuterium-substituteddrugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Deuterium-substituteddrugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Deuterium-substituteddrugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Deuterium-substituteddrugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Deuterium-substituteddrugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Deuterium-substituteddrugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Deuterium-substituteddrugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Deuterium-substituteddrugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Teva Company Details
Table 62. Teva Business Overview
Table 63. Teva Deuterium-substituteddrugs Product
Table 64. Teva Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 65. Teva Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Deuterium-substituteddrugs Product
Table 69. Bristol-Myers Squibb Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Retrotope Company Details
Table 72. Retrotope Business Overview
Table 73. Retrotope Deuterium-substituteddrugs Product
Table 74. Retrotope Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 75. Retrotope Recent Development
Table 76. Alkeus Company Details
Table 77. Alkeus Business Overview
Table 78. Alkeus Deuterium-substituteddrugs Product
Table 79. Alkeus Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 80. Alkeus Recent Development
Table 81. Avanir Company Details
Table 82. Avanir Business Overview
Table 83. Avanir Deuterium-substituteddrugs Product
Table 84. Avanir Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 85. Avanir Recent Development
Table 86. Concert Company Details
Table 87. Concert Business Overview
Table 88. Concert Deuterium-substituteddrugs Product
Table 89. Concert Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 90. Concert Recent Development
Table 91. Processa Company Details
Table 92. Processa Business Overview
Table 93. Processa Deuterium-substituteddrugs Product
Table 94. Processa Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 95. Processa Recent Development
Table 96. Vertex Company Details
Table 97. Vertex Business Overview
Table 98. Vertex Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 99. Vertex Recent Development
Table 100. Jazz Pharmaceuticals Company Details
Table 101. Jazz Pharmaceuticals Business Overview
Table 102. Jazz Pharmaceuticals Deuterium-substituteddrugs Product
Table 103. Jazz Pharmaceuticals Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 104. Jazz Pharmaceuticals Recent Development
Table 105. Zelgen Company Details
Table 106. Zelgen Business Overview
Table 107. Zelgen Deuterium-substituteddrugs Product
Table 108. Zelgen Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 109. Zelgen Recent Development
Table 110. Hinova Pharmaceuticals Inc. Company Details
Table 111. Hinova Pharmaceuticals Inc. Business Overview
Table 112. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Product
Table 113. Hinova Pharmaceuticals Inc. Revenue in Deuterium-substituteddrugs Business (2016-2021) & (US$ Million)
Table 114. Hinova Pharmaceuticals Inc. Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deuterium-substituteddrugs Market Share by Type: 2020 VS 2027
Figure 2. Drugs in Clinical Trials Features
Figure 3. Marketed Drug Features
Figure 4. Global Deuterium-substituteddrugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Deuterium-substituteddrugs Report Years Considered
Figure 9. Global Deuterium-substituteddrugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Deuterium-substituteddrugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Deuterium-substituteddrugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Deuterium-substituteddrugs Market Share by Regions (2022-2027)
Figure 13. Global Deuterium-substituteddrugs Market Share by Players in 2020
Figure 14. Global Top Deuterium-substituteddrugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deuterium-substituteddrugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Deuterium-substituteddrugs Revenue in 2020
Figure 16. Global Deuterium-substituteddrugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Deuterium-substituteddrugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Deuterium-substituteddrugs Market Share by Type (2016-2027)
Figure 20. North America Deuterium-substituteddrugs Market Share by Application (2016-2027)
Figure 21. North America Deuterium-substituteddrugs Market Share by Country (2016-2027)
Figure 22. United States Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Deuterium-substituteddrugs Market Share by Type (2016-2027)
Figure 26. Europe Deuterium-substituteddrugs Market Share by Application (2016-2027)
Figure 27. Europe Deuterium-substituteddrugs Market Share by Country (2016-2027)
Figure 28. Germany Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Deuterium-substituteddrugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Deuterium-substituteddrugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Deuterium-substituteddrugs Market Share by Region (2016-2027)
Figure 38. China Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Deuterium-substituteddrugs Market Share by Type (2016-2027)
Figure 46. Latin America Deuterium-substituteddrugs Market Share by Application (2016-2027)
Figure 47. Latin America Deuterium-substituteddrugs Market Share by Country (2016-2027)
Figure 48. Mexico Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Deuterium-substituteddrugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Deuterium-substituteddrugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Deuterium-substituteddrugs Market Share by Country (2016-2027)
Figure 54. Turkey Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Deuterium-substituteddrugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Teva Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 59. Retrotope Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 60. Alkeus Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 61. Avanir Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 62. Concert Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 63. Processa Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 64. Vertex Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 65. Jazz Pharmaceuticals Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 66. Zelgen Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 67. Hinova Pharmaceuticals Inc. Revenue Growth Rate in Deuterium-substituteddrugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のクロファラビン市場規模・現状・予測（2021年-2027年）

Global Clofarabine Market Size, Status and Forecast 2021-2027
QYR2104Z1384 2021年4月 99Pages
QYResearch社発行の本調査資料では、クロファラビンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エボルトラ、クロファラビン）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のコオキシメトリ市場規模・現状・予測（2021年-2027年）

Global Co-oximetry Market Size, Status and Forecast 2021-2027
QYR2104Z1581 2021年4月 93Pages
QYResearch社発行の本調査資料では、コオキシメトリのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（透過型、反射型）、用途別市場規模（病院、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南ア...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

Global Exostosin 1/2 Heterodimer Market Size, Status and Forecast 2021-2027
QYR2104Z2272 2021年4月 92Pages
QYResearch社発行の本調査資料では、エキソストシン1/2ヘテロダイマーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

Global Micafungin Sodium for Injection Market Size, Status and Forecast 2021-2027
QYR2104Z3743 2021年4月 97Pages
QYResearch社発行の本調査資料では、注射用ミカファンギンナトリウムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（50mg使い捨てバイアル、100mg使い捨てバイアル）、用途別市場規模（カンジダ血症、呼吸器真菌症、胃腸真菌症）、主要地域...

世界の自動車におけるIIoT市場規模・現状・予測（2021年-2027年）

Global IIoT in Automotive Market Size, Status and Forecast 2021-2027
QYR2104Z3027 2021年4月 95Pages
QYResearch社発行の本調査資料では、自動車におけるIIoTのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハードウェア、ソフトウェア、サービス）、用途別市場規模（車内、自動車-自動車、自動車-インフラ）、主要地域別市場規模（北米、アメリ...

世界の先端巨大症治療市場規模・現状・予測（2021年-2027年）

Global Acromegaly Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0034 2021年4月 92Pages
QYResearch社発行の本調査資料では、先端巨大症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オクトレオチド、パシレオチド、ランレオチド、ペグビソマント）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のアルファマンノシドーシス治療市場規模・現状・予測（2021年-2027年）

Global Alpha Mannosidosis Treatments Market Size, Status and Forecast 2021-2027
QYR2104Z0257 2021年4月 92Pages
QYResearch社発行の本調査資料では、アルファマンノシドーシス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（骨髄移植（BMT）、酵素補充療法（ERT））、用途別市場規模（病院、専門クリニック）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

世界のe-臨床試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global e-clinical Trials Market The global e-clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の臨床試験市場規模・現状・予測（2021年-2027年） Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in …
世界の牛乳アレルギー臨床試験レビュー市場規模・現状・予測（2021年-2027年） Cow’s milk allergy (CMA) is among the most common FA in early childhood, with an estimated prevalence of 2% to 3%. The mission for Milk Allergy Clinical Trials is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases. Market Ana…
世界の臨床試験画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Clinical Trials Imaging Market The global Clinical Trials Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
世界の臨床試験画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Clinical Trials Imaging Market The global Clinical Trials Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…